Get started
Author

Stephanie Esosa Joy Areloegbe

Observed names: Areloegbe Stephanie E., Areloegbe, Stephanie E., Esosa Stephanie Areloegbe, S. E. Areloegbe, STEPHANIE ESOSA JOY ARELOEGBE, Stephanie Areloegbe, Stephanie E. Areleogbe, Stephanie E. Areloegbe, Stephanie Eseosa Areloegbe, Stephanie Esosa Areleogbe, Stephanie Esosa Areloegbe
Observed institution: Afe Babalola University
ORCID: 0000-0002-0159-8089
Observed ORCID: 0000-0002-0159-8089
OpenAlex ID: A5018579832
Short chain fatty acid, acetate restores ovarian function in experimentally induced PCOS rat model
2022 · Kehinde S. Olaniyi, Al-amin M. Bashir, et al. · PLoS ONE · 50
PDF
Suppression of PCSK9/NF-kB-dependent pathways by acetate ameliorates cardiac inflammation in a rat model of polycystic ovarian syndrome
2022 · Kehinde S. Olaniyi, Stephanie E. Areloegbe · Life Sciences · 36
Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model
2022 · Stephanie E. Areloegbe, Mmenyene U. Peter, et al. · BMC Endocrine Disorders · 32
PDF
Protective Role of Acetate Against Depressive-Like Behaviour Associated with Letrozole-Induced PCOS Rat Model: Involvement of HDAC2 and DNA Methylation
2022 · John A. Wolugbom, Stephanie E. Areloegbe, et al. · Molecular Neurobiology · 27
PDF
Acetate Restores Hypothalamic-Adipose Kisspeptin Status in a Rat Model of Pcos by Suppression of Nlrp3/ Prokr1 Immunoreactivity
2022 · Kehinde S. Olaniyi, Stephanie E. Areloegbe, et al. · Endocrine · 26
Modulation of GABA by sodium butyrate ameliorates hypothalamic inflammation in experimental model of PCOS
2023 · Oony-Iye Eepho, Al-Amin M. Bashir, et al. · BMC Neuroscience · 22
PDF
Acetate circumvents impaired metabolic switch in skeletal muscle of letrozole-induced PCOS rat model by suppression of PDK4/NLRP3
2022 · Kehinde S. Olaniyi, Stephanie E. Areloegbe · Nutrition · 16
Acetate attenuates hypothalamic pyroptosis in experimentally induced polycystic ovarian syndrome
2024 · Kehinde S. Olaniyi, Shalom U. Agan, et al. · BMC Research Notes · 15
PDF
Acetate ameliorates ovarian mitochondrial dysfunction in letrozole-induced polycystic ovarian syndrome rat model by improving mitofusin-2
2024 · Kehinde S. Olaniyi, Stephanie E. Areloegbe · The Journal of Physiological Sciences · 13
PDF
Cardiac energy depletion in a rat model of polycystic ovarian syndrome is reversed by acetate and associated with inhibitory effect of HDAC2/mTOR
2023 · Kehinde S. Olaniyi, Stephanie E. Areloegbe, et al. · European Journal of Pharmacology · 12
Acetate: A therapeutic candidate against renal disorder in a rat model of polycystic ovarian syndrome
2022 · Kehinde S. Olaniyi, Stephanie E. Areloegbe · The Journal of Steroid Biochemistry and Molecular Biology · 11
Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome
2023 · Kehinde S. Olaniyi, Stephanie E. Areloegbe, et al. · Toxicology and Applied Pharmacology · 10
Probiotics ameliorates hypothalamic amenorrhea in a rat model of PCOS
2025 · Stephanie E. Areloegbe, Nsisong N. Obong, et al. · Metabolic Brain Disease · 9
Acetate mitigates cardiac mitochondrial dysfunction in experimental model of polycystic ovarian syndrome by modulating GPCR41/43 and PROKR1
2023 · Stephanie E. Areloegbe, Kehinde S. Olaniyi · Biochemical and Biophysical Research Communications · 8
Alleviation of adipose–hepatic glycolipid dysregulation by acetate in experimental PCOS model is associated with NF-κB/NLRP3 repression
2023 · Kehinde S. Olaniyi, Stephanie E. Areloegbe · Canadian Journal of Physiology and Pharmacology · 8
Butyrate ameliorates ovarian failure in experimental PCOS rat model by suppression of HDAC2
2025 · Kehinde S. Olaniyi, Christopher O. Akintayo, et al. · Comparative Clinical Pathology · 7
Acetate abates adipose-ovarian endocrinometabolic disturbance in experimentally induced polycystic ovarian syndrome
2024 · Kehinde S. Olaniyi, Stephanie E. Areloegbe, et al. · Steroids · 6
Butyrate-Mediated Modulation of Paraoxonase-1 Alleviates Cardiorenometabolic Abnormalities in a Rat Model of Polycystic Ovarian Syndrome
2024 · Kehinde S. Olaniyi, Stephanie E. Areloegbe, et al. · Cardiovascular Drugs and Therapy · 6
Mineralocorticoid receptor blockade attenuates hyperandrogenic metabolic dysregulation in letrozole-induced PCOS rat model
2022 · Efosa G. Uhunmwangho, Adesola A. Oniyide, et al. · Journal of Diabetes & Metabolic Disorders · 6
Low-dose spironolactone abates cardio-renal disorder by reduction of BAX/inflammasome expression in experimentally induced polycystic ovarian syndrome rat model
2022 · Mmenyene U. Peter, Stephanie E. Areloegbe, et al. · Canadian Journal of Physiology and Pharmacology · 6
Suppression of adipose TGF-β1 by probiotics alleviates metabolic disturbance in experimentally induced PCOS
2025 · Kehinde S. Olaniyi, Doris O. Okara, et al. · Prostaglandins & Other Lipid Mediators · 5
Butyrate alleviates adipose mitochondrial dysfunction and inflammation in experimental model of polycystic ovarian syndrome by modulating SIRT1-dependent mechanism
2024 · Kehinde S. Olaniyi, Stephanie E. Areloegbe · Nutrire · 3
Panax ginseng supplementation protects against testicular damage induced by radiofrequency electromagnetic radiation from cell phone
2023 · Adeoye O. Oyewopo, Olabimpe C. Badejogbin, et al. · Nutrire · 3
Carvone attenuates cardiac fibrosis and inflammation by modulating GSK-3β/PKC-α signalling pathway in experimentally induced polycystic ovarian syndrome
2025 · Kehinde S. Olaniyi, Tubolayefa Bebenimibo, et al. · Toxicology and Applied Pharmacology · 2
Renometabolic disorder in experimental rat model of polycystic ovarian syndrome is reversed by acetate-mediated inhibition of pyruvate dehydrogenase kinase 4
2025 · Stephanie E. Areloegbe, Chukwubueze L. Atuma, et al. · BMC Nephrology · 2
PDF
Works count: 60
Citation count: 354
H-index: 11
I10-index: 12
Year
Topic
Type